Chronic Kidney Disease 5D Clinical Trial
— REFILBIOADMOfficial title:
Bio-adrenomedullin (Bio-ADM) as a Biomarker of Refilling in Chronic Hemodialysis Patient
| NCT number | NCT05339009 |
| Other study ID # | RECHMPL21_0068 |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | April 1, 2022 |
| Est. completion date | May 1, 2023 |
Aim of this study is to evaluate in a population of chronic kidney disease patients on dialysis (Stage 5D) the predictive value of bio-adrenomedullin (bio-ADM) level on vascular refilling rate.
| Status | Recruiting |
| Enrollment | 150 |
| Est. completion date | May 1, 2023 |
| Est. primary completion date | December 31, 2022 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion criteria: - Chronic Kidney Disease patient on dialysis (stage 5D) for more than 1 month - Anuric patient Exclusion criteria: - Patient protected by law - Patient under guardianship ou curatorship - Patient deprived of liberty |
| Country | Name | City | State |
|---|---|---|---|
| France | UH Montpellier | Montpellier |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Montpellier |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Relationship between bio-ADM level and vascular refilling rate | The refilling rate will be assessed by the ratio of relative blood volume and UF max | Day 1 | |
| Secondary | Bio-ADM value according to comorbidity factors | Bio-ADM value according to comorbidity factors (diabetes, heart failure and low-grade inflammation) | Day 1 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05465863 -
Humoral and Cellular İmmune Response to SARS-CoV-2 mRNA BNT162b2 Vaccine in Children With Chronic Kidney Diseases
|
N/A | |
| Recruiting |
NCT06126016 -
A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
|
||
| Not yet recruiting |
NCT05234047 -
Study Evaluating Denosumab on Vascular and Bone Metabolism in Osteoporotic Chronic Kidney Disease (HDENOBS)
|
||
| Completed |
NCT04805632 -
Immune Response in Dialysis Patients Vaccinated Against COVID-19
|
||
| Completed |
NCT05729126 -
The Discrepancy in Radiologists' Practice of Intravenous Contrast Imaging Studies Among Chronic Kidney Disease Patients
|
||
| Completed |
NCT06394986 -
Cardio-fistular Recirculation in Patients With Chronic Heart Failure and Preserved Left Ventricle Ejection Fraction
|
||
| Recruiting |
NCT05071131 -
Effect of Inulin on Gut Microbiota and Gut Barrier in Chronic Kidney Disease
|
N/A | |
| Recruiting |
NCT05549154 -
A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation
|
N/A | |
| Not yet recruiting |
NCT06381076 -
Examining the Impact of High-protein Oral Supplement With Liposomal Curcumin on Inflammation Markers and Oxidative Stress in Adults Undergoing Hemodialysis.
|
N/A | |
| Recruiting |
NCT05805813 -
Cross-control Study on the Effect of Peritoneal Rest on Peritoneal Transport Function in Peritoneal Dialysis Patients
|
N/A |